Published in Annu Rev Immunol on January 01, 2011
Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science (2017) 2.70
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut (2014) 2.36
Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol (2012) 2.09
A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J Exp Med (2013) 1.69
Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol (2013) 1.53
Apoptosis in response to microbial infection induces autoreactive TH17 cells. Nat Immunol (2016) 1.47
Intraepithelial lymphocytes in celiac disease immunopathology. Semin Immunopathol (2012) 1.41
Burden of celiac disease in the Mediterranean area. World J Gastroenterol (2011) 1.29
From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases. Semin Immunopathol (2012) 1.21
Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis (2013) 1.18
IL-15: a central regulator of celiac disease immunopathology. Immunol Rev (2014) 1.14
HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci (2012) 1.08
Reduced-gliadin wheat bread: an alternative to the gluten-free diet for consumers suffering gluten-related pathologies. PLoS One (2014) 1.05
Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am (2012) 1.05
Celiac disease: quantity matters. Semin Immunopathol (2012) 1.03
Association between maternal iron supplementation during pregnancy and risk of celiac disease in children. Clin Gastroenterol Hepatol (2013) 1.01
The adaptive immune response in celiac disease. Semin Immunopathol (2012) 0.97
Early infections are associated with increased risk for celiac disease: an incident case-referent study. BMC Pediatr (2012) 0.96
Refractory celiac disease: from bench to bedside. Semin Immunopathol (2012) 0.95
Structural genes of wheat and barley 5-methylcytosine DNA glycosylases and their potential applications for human health. Proc Natl Acad Sci U S A (2012) 0.93
Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases? Cold Spring Harb Perspect Med (2012) 0.92
Distinct and Synergistic Contributions of Epithelial Stress and Adaptive Immunity to Functions of Intraepithelial Killer Cells and Active Celiac Disease. Gastroenterology (2015) 0.91
Interferon-γ activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: implications for celiac sprue therapy. J Pharmacol Exp Ther (2012) 0.90
THEMIS and PTPRK in celiac intestinal mucosa: coexpression in disease and after in vitro gliadin challenge. Eur J Hum Genet (2013) 0.90
Immune development and intestinal microbiota in celiac disease. Clin Dev Immunol (2012) 0.90
Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol Hepatol (2015) 0.89
Transglutaminase 2 expression is enhanced synergistically by interferon-γ and tumour necrosis factor-α in human small intestine. Clin Exp Immunol (2012) 0.88
Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspective. Intern Med J (2015) 0.88
Gut Microbiota and Celiac Disease. Dig Dis Sci (2016) 0.87
Gluten-sensitive enteropathy coincides with decreased capability of intestinal T cells to secrete IL-17 and IL-22 in a macaque model for celiac disease. Clin Immunol (2013) 0.87
Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease. J Clin Immunol (2012) 0.86
Quantitative phosphoproteome analysis unveils LAT as a modulator of CD3ζ and ZAP-70 tyrosine phosphorylation. PLoS One (2013) 0.86
The contribution of natural selection to present-day susceptibility to chronic inflammatory and autoimmune disease. Curr Opin Immunol (2014) 0.86
Genetics of immune-mediated disorders: from genome-wide association to molecular mechanism. Curr Opin Immunol (2014) 0.86
Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease. J Clin Immunol (2011) 0.86
Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease. J Biol Chem (2015) 0.85
Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplements. PLoS One (2015) 0.85
Lessons from rodent models in celiac disease. Mucosal Immunol (2014) 0.85
Expression analysis in intestinal mucosa reveals complex relations among genes under the association peaks in celiac disease. Eur J Hum Genet (2014) 0.84
Improving the estimation of celiac disease sibling risk by non-HLA genes. PLoS One (2011) 0.84
The intestinal B-cell response in celiac disease. Front Immunol (2012) 0.84
Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens. Nat Rev Rheumatol (2015) 0.83
Immunopathophysiology of food protein-induced enterocolitis syndrome. J Allergy Clin Immunol (2015) 0.81
Quantitative and qualitative differences in celiac disease epitopes among durum wheat varieties identified through deep RNA-amplicon sequencing. BMC Genomics (2013) 0.80
Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa. Int J Mol Sci (2014) 0.80
Broad MICA/B expression in the small bowel mucosa: a link between cellular stress and celiac disease. PLoS One (2013) 0.80
Sourdough fermentation of wheat flour does not prevent the interaction of transglutaminase 2 with α2-gliadin or gluten. Nutrients (2015) 0.80
A genome-wide perspective of human diversity and its implications in infectious disease. Cold Spring Harb Perspect Med (2013) 0.80
Enterocyte proliferation and signaling are constitutively altered in celiac disease. PLoS One (2013) 0.80
The Spectrum of Differences between Childhood and Adulthood Celiac Disease. Nutrients (2015) 0.80
Coeliac disease and gluten-related disorders in childhood. Nat Rev Gastroenterol Hepatol (2015) 0.80
Production of the Main Celiac Disease Autoantigen by Transient Expression in Nicotiana benthamiana. Front Plant Sci (2015) 0.79
Recognition of epidermal transglutaminase by IgA and tissue transglutaminase 2 antibodies in a rare case of Rhesus dermatitis. J Vis Exp (2011) 0.79
Salivary proline-rich proteins and gluten: Do structural similarities suggest a role in celiac disease? Proteomics Clin Appl (2015) 0.79
The effects of reduced gluten barley diet on humoral and cell-mediated systemic immune responses of gluten-sensitive rhesus macaques. Nutrients (2015) 0.79
CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes. Proc Natl Acad Sci U S A (2017) 0.79
Coeliac Disease - New Pathophysiological Findings and Their Implications for Therapy. Viszeralmedizin (2014) 0.79
Latest in vitro and in vivo models of celiac disease. Expert Opin Drug Discov (2013) 0.79
Identification of a serum transglutaminase threshold value for the noninvasive diagnosis of symptomatic adult celiac disease patients: a retrospective study. J Gastroenterol (2016) 0.79
The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Semin Immunopathol (2012) 0.78
A celiac cellular phenotype, with altered LPP sub-cellular distribution, is inducible in controls by the toxic gliadin peptide P31-43. PLoS One (2013) 0.78
Common polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility loci. Eur J Hum Genet (2015) 0.78
Elderly Onset Celiac Disease: A Narrative Review. Clin Med Insights Gastroenterol (2016) 0.78
Matrix expansion and syncytial aggregation of syndecan-1+ cells underpin villous atrophy in coeliac disease. PLoS One (2014) 0.78
Network-based analysis of omics data: The LEAN method. Bioinformatics (2016) 0.77
Patterns of population differentiation and natural selection on the celiac disease background risk network. PLoS One (2013) 0.77
Self-Reported Prevalence of Gluten-Related Disorders and Adherence to Gluten-Free Diet in Colombian Adult Population. Gastroenterol Res Pract (2016) 0.77
Expression Pattern of Fatty Acid Binding Proteins in Celiac Disease Enteropathy. Mediators Inflamm (2015) 0.77
Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease. Am J Physiol Gastrointest Liver Physiol (2014) 0.77
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics. PLoS One (2013) 0.77
Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients. Nutrients (2013) 0.77
Screening for coeliac disease in adult patients with type 1 diabetes mellitus: myths, facts and controversy. Diabetol Metab Syndr (2016) 0.76
Serum markers in the clinical management of celiac disease. Dig Dis (2015) 0.76
The cross-talk between enterocytes and intraepithelial lymphocytes. Mol Cell Pediatr (2016) 0.76
Current Status of Celiac Disease Drug Development. Am J Gastroenterol (2016) 0.75
Innate immunity: actuating the gears of celiac disease pathogenesis. Best Pract Res Clin Gastroenterol (2015) 0.75
Coeliac disease and autoimmune disease-genetic overlap and screening. Nat Rev Gastroenterol Hepatol (2015) 0.75
Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications. Nutrients (2015) 0.75
Another earth: innate lymphoid cells and intestinal inflammation. Gastroenterology (2011) 0.75
Genomic prediction of celiac disease targeting HLA-positive individuals. Genome Med (2015) 0.75
Identification of food-grade subtilisins as gluten-degrading enzymes to treat celiac disease. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Recent Advances in Celiac Disease. Indian J Pediatr (2016) 0.75
Immunopathogenesis and therapeutic approaches in pediatric celiac disease. Expert Rev Clin Immunol (2016) 0.75
BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity. PLoS One (2014) 0.75
Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum. Nutrients (2015) 0.75
Celiac disease and Down syndrome mortality: a nationwide cohort study. BMC Pediatr (2017) 0.75
A biased view toward celiac disease. Mucosal Immunol (2016) 0.75
Diagnosis of coeliac disease in children in primary care and clinical implications. Br J Gen Pract (2014) 0.75
Does celiac disease influence survival in lymphoproliferative malignancy? Eur J Epidemiol (2013) 0.75
Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease. Sci Rep (2016) 0.75
Exploring T cell reactivity to gliadin in young children with newly diagnosed celiac disease. Autoimmune Dis (2014) 0.75
Lectin staining shows no evidence of involvement of glycocalyx/mucous layer carbohydrate structures in development of celiac disease. Nutrients (2013) 0.75
Coeliac disease: a unique model for investigating broken tolerance in autoimmunity. Clin Transl Immunology (2016) 0.75
Humans as cucinivores: comparisons with other species. J Comp Physiol B (2015) 0.75
Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosis. J Clin Immunol (2013) 0.75
The Role of Environmental Factors in the Development of Celiac Disease: What Is New? Diseases (2015) 0.75
Structural basis for gluten intolerance in celiac sprue. Science (2002) 8.16
The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science (2011) 6.01
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature (2012) 5.63
Coeliac disease. Lancet (2003) 4.47
Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity (2004) 4.36
Plague bacteria target immune cells during infection. Science (2005) 3.32
HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol (2003) 3.17
Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology (2002) 2.95
Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A (2004) 2.33
The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe (2007) 2.26
Inferring the demographic history of African farmers and pygmy hunter-gatherers using a multilocus resequencing data set. PLoS Genet (2009) 2.07
Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med (2006) 2.03
Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol (2009) 1.91
Risk of malignancy in patients with celiac disease. Am J Med (2003) 1.85
Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci U S A (2008) 1.82
Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease. Gastroenterology (2005) 1.70
Mechanisms of disease: immunopathogenesis of celiac disease. Nat Clin Pract Gastroenterol Hepatol (2006) 1.68
Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One (2008) 1.67
HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest (2006) 1.66
Social environment is associated with gene regulatory variation in the rhesus macaque immune system. Proc Natl Acad Sci U S A (2012) 1.63
Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. J Proteome Res (2005) 1.63
Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue. Biochem J (2004) 1.63
Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe (2008) 1.59
Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J Biol Chem (2002) 1.57
LcrV plague vaccine with altered immunomodulatory properties. Infect Immun (2005) 1.57
Effective shutdown in the expression of celiac disease-related wheat gliadin T-cell epitopes by RNA interference. Proc Natl Acad Sci U S A (2010) 1.57
Formulating a historical and demographic model of recent human evolution based on resequencing data from noncoding regions. PLoS One (2010) 1.55
Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol (2013) 1.53
Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation. J Immunol (2005) 1.51
Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon. PLoS One (2010) 1.45
High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med (2012) 1.44
Intraepithelial lymphocytes in celiac disease immunopathology. Semin Immunopathol (2012) 1.41
The molecular basis for oat intolerance in patients with celiac disease. PLoS Med (2004) 1.40
Redox regulation of transglutaminase 2 activity. J Biol Chem (2010) 1.38
Celiac disease. Annu Rev Med (2006) 1.35
Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J Clin Invest (2008) 1.34
Evolutionary genetic dissection of human interferons. J Exp Med (2011) 1.32
Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc Natl Acad Sci U S A (2007) 1.32
The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR. Eur J Immunol (2012) 1.24
Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology (2003) 1.24
Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion. J Immunol (2004) 1.23
Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. Am J Hum Genet (2006) 1.23
Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat Immunol (2009) 1.22
Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun (2006) 1.21
Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm Bowel Dis (2007) 1.21
Assessing possible celiac disease by an HLA-DQ2-gliadin Tetramer Test. Am J Gastroenterol (2011) 1.19
Rapid generation of rotavirus-specific human monoclonal antibodies from small-intestinal mucosa. J Immunol (2010) 1.19
Signature-tagged transposon mutagenesis identifies novel Mycobacterium tuberculosis genes involved in the parasitism of human macrophages. Infect Immun (2006) 1.19
Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity. Am J Gastroenterol (2013) 1.18
Pathomechanisms in celiac disease. Best Pract Res Clin Gastroenterol (2005) 1.18
Signatures of purifying and local positive selection in human miRNAs. Am J Hum Genet (2009) 1.18
Heterologous expression, purification, refolding, and structural-functional characterization of EP-B2, a self-activating barley cysteine endoprotease. Chem Biol (2006) 1.17
The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature (2008) 1.16
Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization. J Pharmacol Exp Ther (2004) 1.15
Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem (2004) 1.15
IL-15: a central regulator of celiac disease immunopathology. Immunol Rev (2014) 1.14
Is celiac disease an autoimmune disorder? Curr Opin Immunol (2005) 1.14
Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. J Exp Med (2009) 1.14
Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders. Curr Opin Immunol (2011) 1.13
Equilibrium and kinetic analysis of the unusual binding behavior of a highly immunogenic gluten peptide to HLA-DQ2. Biochemistry (2005) 1.11
Posttranslational modification of gluten shapes TCR usage in celiac disease. J Immunol (2011) 1.11
Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles. Hum Mol Genet (2006) 1.09
A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology (2006) 1.08
A specific role for TLR1 in protective T(H)17 immunity during mucosal infection. J Exp Med (2012) 1.07
Age-dependent association between pulmonary tuberculosis and common TOX variants in the 8q12-13 linkage region. Am J Hum Genet (2013) 1.06
Regional differences in colonic mucosa-associated microbiota determine the physiological expression of host heat shock proteins. Am J Physiol Gastrointest Liver Physiol (2010) 1.05
Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am (2012) 1.05
The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes. PLoS One (2010) 1.05
Gluten T cell epitope targeting by TG3 and TG6; implications for dermatitis herpetiformis and gluten ataxia. Amino Acids (2010) 1.04
Densely granulated murine NK cells eradicate large solid tumors. Cancer Res (2012) 1.04
Activation of extracellular transglutaminase 2 by thioredoxin. J Biol Chem (2011) 1.03
Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization. J Immunol (2007) 1.02
Long-lived plasma cells from human small intestine biopsies secrete immunoglobulins for many weeks in vitro. J Immunol (2011) 1.00
Phosphate-containing polyethylene glycol polymers prevent lethal sepsis by multidrug-resistant pathogens. Antimicrob Agents Chemother (2013) 1.00
Potential celiac patients: a model of celiac disease pathogenesis. PLoS One (2011) 0.99
Antigen presentation in celiac disease. Curr Opin Immunol (2009) 0.98
Celiac disease and other precursors to small-bowel malignancy. Gastroenterol Clin North Am (2002) 0.98
Specific modification of peptide-bound citrulline residues. Anal Biochem (2006) 0.98
The adaptive immune response in celiac disease. Semin Immunopathol (2012) 0.97
Inhibition of HLA-DQ2-mediated antigen presentation by analogues of a high affinity 33-residue peptide from alpha2-gliadin. J Am Chem Soc (2006) 0.97
Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients. PLoS One (2009) 0.97
The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Biochim Biophys Acta (2008) 0.96
Tolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T cells. Gastroenterology (2011) 0.96
Vaccine against autoimmune disease: antigen-specific immunotherapy. Curr Opin Immunol (2013) 0.94
The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity. J Clin Invest (2010) 0.93
A mouse C kappa-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation. Int Immunol (2002) 0.93
A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease. J Proteome Res (2009) 0.93
Biased usage and preferred pairing of α- and β-chains of TCRs specific for an immunodominant gluten epitope in coeliac disease. Int Immunol (2013) 0.93
T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease. Gastroenterology (2011) 0.92
Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells. J Immunol (2013) 0.91
Noninflammatory gluten peptide analogs as biomarkers for celiac sprue. Chem Biol (2009) 0.91
Meta and pooled analysis of European coeliac disease data. Eur J Hum Genet (2003) 0.91
Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires. Immunogenetics (2014) 0.91
Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation. Mol Biol Evol (2011) 0.90
Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα. Proc Natl Acad Sci U S A (2013) 0.90
A genomic portrait of the genetic architecture and regulatory impact of microRNA expression in response to infection. Genome Res (2014) 0.90
IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner. Proc Natl Acad Sci U S A (2013) 0.90
Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles. Immunogenetics (2003) 0.90
Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules. Hum Immunol (2008) 0.89